Hypercoagulable States

Published on 04/03/2015 by admin

Filed under Hematology, Oncology and Palliative Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1489 times

Chapter 63 Hypercoagulable States

Table 63-3 Causes of Acquired Antithrombin Deficiency

Decreased Synthesis Increased Consumption Enhanced Clearance
Hepatic cirrhosis Major surgery Heparin
Severe liver disease Acute thrombosis Nephrotic syndrome
l-asparaginase Disseminated intravascular coagulation  
  Severe sepsis  
  Multiple trauma  
  Malignancy  
  Prolonged extracorporeal circulation  

Table 63-4 Types of Inherited Protein C Deficiency

Type Antigen Activity
I Low Low
II Normal Low

Table 63-6 Features of Heparin-Induced Thrombocytopenia

Feature Details
Thrombocytopenia Platelet count of 100,000/µl or less or a decrease in platelet count of 50% or more
Timing Platelet count falls 5 to 10 days after starting heparin
Type of heparin More common with unfractionated heparin than LMWH
Type of patient More common in surgical patients than medical patients; more common in women than in men
Thrombosis Venous thrombosis more common than arterial thrombosis

Routine Investigations to Evaluate a Patient With (Venous) Thrombosis

Test Abnormality Diagnostic Information
Complete blood count Elevated hematocrit
Increased white count
Increased platelet count
Leukopenia
Thrombocytopenia
Myeloproliferative disorder (e.g., essential thrombocythemia, polycythemia vera); may be found in paroxysmal nocturnal hemoglobinuria; if associated with heparin administration, consider heparin-induced thrombocytopenia
Blood film Leukoerythroblastic film Underlying neoplasm invading bone marrow
Liver function tests Abnormal tests May point to malignancy
Renal function Impaired renal function Assess prior to anticoagulation with heparin or LMWH
Urinalysis Proteinuria Nephrotic syndrome; may be associated with venous thromboembolism or renal vein thrombosis
PT and aPTT Prolonged PT and aPTT To enable safe anticoagulation to proceed if required
Need to exclude lupus anticoagulant